This invariant subset could promote cancer growth through the γδ T/IL-17A/small peritoneal macrophages axis and protect against intestinal infection depending on the production of interferon gamma (IFN-γ) and IL-17A21, 22. Here, IFNG is linked to digestive system infectious disorder.